Optimizing Tissue Biopsy and Disease Staging in Early-Stage NSCLC

featured-image

Panelists discuss how medical professionals frequently encounter tissue adequacy challenges in comprehensive genomic profiling for early-stage non–small cell lung cancer (NSCLC), employing strategies such as optimized biopsy techniques, efficient tissue triage protocols, and complementary liquid biopsies to ensure sufficient material for complete molecular analysis.

Video content above is prompted by the following: Tissue Adequacy Challenges in Comprehensive Genomic Profiling for Early-Stage NSCLC Prevalence of Tissue Adequacy Challenges Medical professionals frequently encounter tissue adequacy issues when performing comprehensive genomic profiling (CGP) in early-stage NSCLC. Insufficient tissue quantity and quality represent significant barriers to complete molecular assessment, potentially compromising therapeutic decision-making. Current Mitigation Strategies Clinicians employ several approaches to address tissue limitations: Optimization of Biopsy Techniques To improve tissue, yield and adequacy: Tissue Triage Best Practices Effective tissue management includes: Role of Liquid Biopsies Liquid biopsies are emerging as complementary or alternative options:.